Maggie is a senior editor for The American Journal of Managed Care® (AJMC®) and produces written, video, and podcast content covering several disease states. She joined AJMC® in 2019, and has been with AJMC®’s parent company, MJH Life Sciences®, since 2014, when she started as a copy editor.
She has a BA in English from Penn State University. You can connect with Maggie on LinkedIn.
Novel Modeling Approach Improves Health Equity in HIV
An abstract presented at IAS 2021, this year's virtual annual meeting of the International AIDS Society, addressed health care disparities that persist among persons living with HIV, with the ultimate goal being to improve health equity for this patient population.
Dr Mikhail N. Kosiborod: DARE-19 Results Do Not Support SGLT2 Treatment Discontinuation
Patients should continue to be monitored while on treatment with SGLT2 inhibitors if they are being treated for comorbid type 2 diabetes and heart failure, emphasized Mikhail N. Kosiborod, MD, cardiologist, vice president of Research at Saint Luke's Health System.
Dr Todd Schlesinger: Surgical Decisions for Skin Cancer Are Multimodal
The characteristics of the tumor and the presence of surgical fatigue can help determine patients’ candidacy for skin cancer surgery, explained Todd Schlesinger, MD, FAAD, director, Dermatology and Laser Center of Charleston and Clinical Research Center of the Carolinas.
Dr Perry N. Halkitis: To Eradicate HIV, We Must Deal With Structural Inequities
By 2020, UNAIDS had hoped to meet the 90-90-90 goal it originally set in 2014: to have 90% of people living with HIV know their status, 90% be on antiretroviral therapy (ART), and 90% have achieved viral suppression. The world fell short of meeting that goal, with just 81% knowing their positive status, two-thirds on ART, and 59% being virally suppressed.
Early Intensive DMT Use May Prevent Greater Long-term Disability in RRMS
Early intensive treatment was more efficacious at slowing disease accumulation in patients with relapsing-remitting multiple sclerosis (RRMS) vs initiating therapy with a moderate-efficacy disease-modifying treatment (DMT) prior to switching to a higher-efficacy DMT.
Increased Sudden Cardiac Death, Myocardial Fibrosis Seen in Persons Living With HIV
Compared with individuals without known HIV infection, persons living with HIV had higher rates of sudden cardiac death and increased interstitial myocardial fibrosis in a new New England Journal of Medicine study.
Adults With MS, Comorbidities Shoulder Significant Economic, Health Burdens
The study authors hope their findings inform future interventions whose goal is to minimize the comorbidity burden of adults with multiple sclerosis (MS), thereby improving their quality of life and ultimate health outcomes.
Lower Risk of Relapse Seen Among UK Children With RRMS Receiving Newer DMTs
Compared with their peers receiving injectable treatments for their relapsing-remitting multiple sclerosis (RRMS), children who received newer disease-modifying therapies (DMTs) had improved scores on several measures of disease progression.
Elderly Patients With Heart Failure May Benefit From Progressive Rehabilitation
Progressive rehabilitation produced superior results among patients randomized to a 36-session program during or following hospitalization for acute decompensated heart failure vs those randomized to usual care.
A Q&A With HIV/AIDS Pioneer Dr Michael Gottlieb
This week marks the 40th anniversary of the CDC's June 5, 1981, Morbidity and Mortality Weekly Report describing rare instances of immunocompromised status among 5 homosexual men in Los Angeles. The American Journal of Managed Care® spoke recently with lead author Michael Gottlieb, MD, who was the first to describe what would come to be known as HIV and AIDS.